Symtuza is a prescription medicine used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults who have not received anti-HIV-1 treatment. HIV-1 causes Acquired Immune Deficiency Syndrome (AIDS).
Active ingredient in Symtuza: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide and inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose. The tablets are film-coated with a coating material containing polyethylene glycol (macrogol), polyvinyl alcohol (partially hydrolyzed), talc, titanium dioxide, and yellow ferric oxide.
Common side effects of Symtuza are; changes in immune system (Immune Reconstitution Syndrome) worse kidney problems, including kidney failure, too much lactic acid in the blood-lactic acidosis, weakness, unusual muscle pain, fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet and feeling dizzy.